# Ajax Therapeutics, Inc. — Form D

Ajax Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-13. The offering totals $95.0M, of which $95.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-05-13
- Form: D
- Accession: 0001780490-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $95.0M
- Amount sold: $95.0M
- Investors: 21
- Date of first sale: 2024-04-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-513064

## Issuer

- Name: Ajax Therapeutics, Inc.
- CIK: 0001780490
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 275 MADISON AVE, 39TH FLOOR, NEW YORK, NY, 10016
- Phone: 917-410-7250

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Ramy Farid | Director | New York, NY |
| Ross Levine | Director | New York, NY |
| Scott Platshon | Director | New York, NY |
| Martin Vogelbaum | Director | New York, NY |
| Martin Vogelbaum | Executive Officer | New York, NY |
| David Schnell | Director | New York, NY |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-06-01](https://search.stillhousedata.com/formd/0001231919-21-000051) | D | $40.0M | $37.4M |
| [2019-06-28](https://search.stillhousedata.com/formd/0001231919-19-000035) | D | $8.0M | $8.0M |

## More

- [CIK 1780490 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1780490&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001780490-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.